During the recent session, Lilly(Eli) & Co (NYSE:LLY)’s traded shares were 0.98 million, with the beta value of the company hitting 0.39. At the last check today, the stock’s price was $734.05, reflecting an intraday gain of 1.59% or $11.48. The 52-week high for the LLY share is $972.53, that puts it down -32.49 from that peak though still a striking 7.76% gain since the share price plummeted to a 52-week low of $677.09. The company’s market capitalization is $695.69B, and the average intraday trading volume over the past 10 days was 3.83 million shares, and the average trade volume was 4.17 million shares over the past three months.
Lilly(Eli) & Co (LLY) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.52. LLY has a Sell rating from 0 analyst(s) out of 19 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 17 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 5.53.
Lilly(Eli) & Co (NYSE:LLY) trade information
Lilly(Eli) & Co (LLY) registered a 1.59% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.59% in intraday trading to $734.05, hitting a weekly high. The stock’s 5-day price performance is 2.64%, and it has moved by -18.34% in 30 days. Based on these gigs, the overall price performance for the year is -9.14%. The short interest in Lilly(Eli) & Co (NYSE:LLY) is 7.35 million shares and it means that shorts have 1.46 day(s) to cover.
The consensus price target of analysts on Wall Street is $970, which implies an increase of 24.32% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $700 and $1146 respectively. As a result, LLY is trading at a discount of -56.12% off the target high and 4.64% off the low.
Lilly(Eli) & Co (LLY) estimates and forecasts
In the rating firms’ projections, revenue will increase 32.24% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 14.34B as predicted by 17 analyst(s). Meanwhile, a consensus of 16 analyst(s) estimates revenue growth to 15.37B by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 11.3B and 11.44B respectively. In this case, analysts expect current quarter sales to grow by 26.87% and then jump by 34.40% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 18.77%. While earnings are projected to return 67.75% in 2025, the next five years will return 41.43% per annum.
LLY Dividends
Lilly(Eli) & Co is due to release its next quarterly earnings on 2025-Apr-30. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Lilly(Eli) & Co is 5.60, with the dividend yield indicating at 0.76 percent, continuing the trend of increasing dividends in recent years. The average dividend yield of the company for the last 5 years is 1.13%.
Lilly(Eli) & Co (NYSE:LLY)’s Major holders
Lilly(Eli) & Co insiders own 0.16% of total outstanding shares while institutional holders control 84.03%, with the float percentage being 84.16%. LILLY ENDOWMENT INC is the largest shareholder of the company, while 4987.0 institutions own stock in it. As of 2024-06-30, the company held over 97.37 million shares (or 10.8078% of all shares), a total value of $88.15 billion in shares.
The next largest institutional holding, with 73.86 million shares, is of VANGUARD GROUP INC’s that is approximately 8.1984% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $66.87 billion.
Also, the Mutual Funds coming in first place with the largest holdings of Lilly(Eli) & Co (LLY) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund . Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 26.96 shares. This amounts to just over 2.84 percent of the company’s overall shares, with a $19.75 billion market value. The same data shows that the other fund manager holds slightly less at 21.89, or about 2.31% of the stock, which is worth about $16.04 billion.
